Article Text
Treatment
Randomised controlled trial
Catheter ablation treatment for paroxysmal atrial fibrillation results in a longer time to treatment failure than anti-arrhythmic drugs and improves quality of life
Statistics from Altmetric.com
Footnotes
-
Competing interests NFM has acted as a paid consultant for Boehringer-Ingelheim, eCardio Diagnostics, Sanofi-Aventis and Surgivision; has received research funding from Surgivision; and been an invited speaker for Biosense Webster, Biotronik, Boehringer-Ingelheim, Boston Scientific, eCardio Diagnostics, Medtronic, Sanofi-Aventis, St Jude and Surgivision.